Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 58 min 12 sec ago

Aurora Spine Announces Expansion of U.S. Hospital Network Through Agreement With MedAssets

Thu, 10/23/2014 - 16:11
CARLSBAD, CALIFORNIA--(Healthcare Sales & Marketing Network) - Aurora Spine Corporation (TSX VENTURE:ASG) announced it has entered into a national contract with MedAssets. MedAssets is one of the nation's largest third-party providers of supply chain manag...
Devices, Orthopaedic, Neurosurgery, Distribution
Aurora Spine, MedAssets

AbVitro Inc. Appoints Jeffrey M. Ostrove, Ph.D. as Chief Executive Officer

Thu, 10/23/2014 - 16:08
BOSTON, Oct. 23, 2014 -- (Healthcare Sales & Marketing Network) -- AbVitro Inc., a therapeutic target discovery company, announced that Jeffrey M. Ostrove, Ph.D. has been appointed as chief executive officer and director of the Company. Dr. Ostrove brings...
Biopharmaceuticals, Personnel
AbVitro

Quartet Medicine Launches with $17 Million Series A Financing

Thu, 10/23/2014 - 15:51
Company to explore broad applications for modulators of tetrahydrobiopterin (BH4) synthesis in the treatment of chronic pain and inflammation CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Quartet Medicine, a biotechnology company focused on ...
Biopharmaceuticals, Venture Capital
Quartet Medicine, tetrahydrobiopterin

Raptor Pharmaceutical Announces Management Changes

Thu, 10/23/2014 - 15:48
NOVATO, Calif., Oct. 23, 2014 -- (Healthcare Sales & Marketing Network) -- Raptor Pharmaceutical Corp. (RPTP) today announced that it has strengthened its leadership team with the hiring of two new executives: David Happel, Chief Commercial Officer, who wi...
Biopharmaceuticals, Personnel
Raptor Pharmaceutical, nephropathic cystinosis

Gamma Medica Secures $11.5 Million in Growth Financing

Wed, 10/22/2014 - 15:47
Award-winning molecular breast imaging company plans global marketing and sales expansion SALEM, N.H.--(Healthcare Sales & Marketing Network)--Gamma Medica, a developer of advanced digital molecular imaging technologies, announced today a $6.5 million g...
Devices, Radiology, Oncology, Venture Capital
Gamma Medica, LumaGEM, Molecular Breast Imaging

Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors

Wed, 10/22/2014 - 15:44
MADISON, N.J., Oct. 22, 2014 -- (Healthcare Sales & Marketing Network) -- Quest Diagnostics (DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Jeffrey M. Leiden, M.D., Ph.D., to ...
Diagnostics, Personnel
Quest Diagnostics

aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research

Wed, 10/22/2014 - 15:41
Architect of Novel Translational Rare Disease Programs at NIH Adds Depth to Existing Team of Rare Disease Experts SAN DIEGO and HONG KONG, Oct. 22, 2014 -- (Healthcare Sales & Marketing Network) -- aTyr Pharma ("aTyr"), an innovative rare dis...
Biopharmaceuticals, Personnel
aTyr Pharma, Physiocrine

Atossa Genetics Receives CE Mark for the ForeCYTE Breast Aspirator Device

Wed, 10/22/2014 - 15:37
SEATTLE, WA--(Healthcare Sales & Marketing Network) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced it has received certification to Annex II of the European Medical Device Directive (MDD) from its European Notified Body, DQS Medizinprodukte GmbH, wh...
Devices, Diagnostics, Oncology, Regulatory
Atossa Genetics, ForeCYTE Breast Aspirator

Otonomy Appoints Anthony J. Yost Chief Commercial Officer

Tue, 10/21/2014 - 12:46
SAN DIEGO, Oct. 21, 2014 -- (Healthcare Sales & Marketing Network) -- Otonomy, Inc. (OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and m...
Biopharmaceuticals, Personnel
Otonomy Inc

Viamet Announces $60 Million Series D Financing

Tue, 10/21/2014 - 12:40
RESEARCH TRIANGLE PARK, N.C.--(Healthcare Sales & Marketing Network)--Viamet Pharmaceuticals Holdings, LLC (Viamet) today announced the closing of a $60 million Series D financing provided by Brandon Point Industries Limited (Brandon Point) working with Wo...
Biopharmaceuticals, Venture Capital
Viamet Pharmaceuticals

NeuroSigma Receives Notice of Allowance of U.S. Patent Application

Tue, 10/21/2014 - 12:35
Subcutaneous Trigeminal Nerve Stimulation (sTNS) for the Treatment of Neuropsychiatric Disorders LOS ANGELES, Oct. 21, 2014 -- (Healthcare Sales & Marketing Network) – NeuroSigma®, Inc. (NeuroSigma), a California-based life sciences company focused...
Devices, Neurology
NeuroSigma, Monarch eTNS system, trigeminal nerve stimulation

Medrobotics Closes $20 Million Financing

Tue, 10/21/2014 - 12:29
Company Extends its Runway for Commercialization of the Ground-Breaking Flex® System in Otolaryngology RAYNHAM, Mass.--(Healthcare Sales & Marketing Network)--Medrobotics Corp., a surgical products company with core competencies in medical robotics,...
Devices, Surgery, Venture Capital
Medrobotics, Flex System, Flex Retractor, robotic surgery

Interim Chief Financial Officer James Bowling to Step Down

Mon, 10/20/2014 - 12:26
DUBLIN, October 20, 2014 -- (Healthcare Sales & Marketing Network) --Shire plc (LSE: SHP, NASDAQ: SHPG) announces that James Bowling, Interim Chief Financial Officer (CFO), has notified the Board of Directors of his decision to step down from his current ...
Biopharmaceuticals, Personnel
Shire plc

Incyte Appoints David Gryska as Executive Vice President and Chief Financial Officer

Fri, 10/17/2014 - 18:39
WILMINGTON, Del.--(Healthcare Sales & Marketing Network)--Incyte Corporation (INCY) today announced the appointment of David Gryska as Executive Vice President and Chief Financial Officer, effective October 31, 2014. Mr. Gryska will report to Hervé ...
Biopharmaceuticals, Oncology, Personnel
Incyte

EYLEA(R) (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study

Fri, 10/17/2014 - 13:40
TARRYTOWN, N.Y., Oct. 17, 2014 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that in the National Institutes of Health (NIH) sponsored, Diabetic Retinopathy Clinical Research Network (DRCR.net)...
Biopharmaceuticals, Ophthalmology
Regeneron Pharmaceuticals, EYLEA, aflibercept, Diabetic Macular Edema

Natus Medical Announces First of Kind Vista Ultrasound System

Thu, 10/16/2014 - 13:39
PLEASANTON, Calif., Oct. 16, 2014 -- (Healthcare Sales & Marketing Network) -- Natus Medical Incorporated (BABY) today announced the launch of the Vista Ultrasound System. The Vista Ultrasound System is the first product in the market to enable the use of ...
Devices, Product Launch
Natus Medical, Vista Ultrasound System

Lombard Medical Announces First Aorfix(TM) Cases in New Zealand Following Expansion in Asia-Pacific Region

Thu, 10/16/2014 - 13:35
Cases Led by Prof. Andrew Holden, Globally-Recognized Expert on Endovascular Treatments IRVINE, Calif. and LONDON, Oct. 16, 2014 -- (Healthcare Sales & Marketing Network) -- Lombard Medical, Inc. (EVAR), a medical device company focused on Endovascular ...
Devices, Interventional
Lombard Medical, Endovascular Aneurysm Repair, Aorfix, AAA

FDA Approves Boehringer Ingelheim's OFEV(R) (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis

Thu, 10/16/2014 - 13:29
Company to make OFEV available to IPF community within 10 days, along with comprehensive patient support resources Approval based on clinical trial program of more than 1,200 IPF patients RIDGEFIELD, Conn., Oct. 15, 2014 -- (Healthcare Sales & Market...
Biopharmaceuticals, FDA
Boehringer Ingelheim Pharmaceuticals, OFEV , nintedanib

Portal Instruments Completes Landmark $11 Million Series A Financing to Develop Innovative Drug Delivery Platform

Wed, 10/15/2014 - 17:11
Sanofi, PBJ Capital, and a Major US Medical Device Company Provide Initial Financing for Breakthrough Medical Device Company CAMBRIDGE, Mass., Oct. 15, 2014 -- (Healthcare Sales & Marketing Network) -- Portal Instruments, Inc., a new dynamic, emerging ...
Devices, Drug Delivery, Venture Capital
Portal Instruments, needle-free drug delivery

Breg And United Orthopedic Group Announce Merger

Wed, 10/15/2014 - 16:42
Combination Creates a Leading U.S. Provider of Sports Medicine and Rehabilitative Orthopedic Products and Services CARLSBAD, Calif. and PLANO, Texas, Oct. 15, 2014 -- (Healthcare Sales & Marketing Network) -- Breg, Inc. and United Orthopedic Group, Inc...
Devices, Orthopaedic, Mergers & Acquisitions
Breg , United Orthopedic Group

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong